Funded Startups in Kuopio
Five most recent Kuopio-area funding rounds span from 2022-06-13 (Adamant Health) to 2026-02-06 (Capalo AI).
Five most recent Kuopio-area funding rounds span from 2022-06-13 (Adamant Health) to 2026-02-06 (Capalo AI). The disclosed amounts show a clear outlier: FinVector’s $48M (2023-06-07) is the only round above $10M, dwarfing the next-largest disclosed amount of $13M (Capalo AI on 2026-02-06) and leaving the remaining entries clustered at $9M, $3M, and $2M. Sector-wise, Health Care, Biotechnology, and AI all appear, but Biotechnology has the densest representation with two entries (FinVector and Aurealis Therapeutics), while stage labels are less consistent: two rounds are “Series Unknown,” alongside one Seed and one Series A. Timing also clusters into two bursts: two entries in 2023–2024 (FinVector $48M on 2023-06-07 and Aurealis Therapeutics $9M on 2024-11-13) and two more in the last 12 months covered here (Marginum $3M on 2025-08-22 and Capalo AI $13M on 2026-02-06).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round among Kuopio entries shown, and how does it compare to the rest?
FinVector’s $48M on 2023-06-07 is the standout: it is the only disclosed amount above $10M, with the next-largest being Capalo AI’s $13M (2026-02-06). The remaining disclosed rounds sit lower at $9M (Aurealis Therapeutics, 2024-11-13), $3M (Marginum, 2025-08-22), and $2M (Adamant Health, 2022-06-13).
Do any funding rounds cluster tightly by date within the five most recent rows?
Yes. Two entries fall in the 2025–2026 window (Marginum $3M on 2025-08-22 and Capalo AI $13M on 2026-02-06), while another pair lands in 2023–2024 (FinVector $48M on 2023-06-07 and Aurealis Therapeutics $9M on 2024-11-13). The oldest row is Adamant Health (Seed $2M on 2022-06-13).
Is Kuopio represented across multiple sectors here, and which one appears most often?
Three sectors show up across the five companies: Health Care (Marginum $3M on 2025-08-22; Adamant Health $2M on 2022-06-13), Biotechnology (FinVector $48M on 2023-06-07; Aurealis Therapeutics $9M on 2024-11-13), and Artificial Intelligence (Capalo AI $13M on 2026-02-06). Biotechnology is the most frequent sector with 2 of 5 entries.
How does the stage mix look across these five rows?
Stage labeling is split. “Series Unknown” appears in two of the five entries (Aurealis Therapeutics $9M on 2024-11-13; FinVector $48M on 2023-06-07), while the remaining three are more specific: Seed for Marginum ($3M, 2025-08-22) and Adamant Health ($2M, 2022-06-13), and Series A for Capalo AI ($13M, 2026-02-06).
Are there notable outliers besides the largest disclosed amount?
On the high end, FinVector’s $48M (2023-06-07) is far above the rest of the disclosed amounts (next-largest $13M, with the rest at $9M, $3M, and $2M). On the low end, Adamant Health’s $2M (2022-06-13) is the smallest disclosed round, well separated from Marginum’s $3M (2025-08-22) and the rest.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.